Skip to main content
. 2022 Nov 29;12(11):e063659. doi: 10.1136/bmjopen-2022-063659

Table 2.

Summary of meta-analyses which pooled the ratios of BMI assessment by patient groups

Predictor Comparison No of studies Pooled risk ratio I2, heterogeneity test, p value
Demographics
 Sex Female vs male (reference) 15 1.28 (1.10,1.50) 99.8%, p<0.001
 Age Closest to 65 years vs closest to 30 years (reference) 12 0.90 (0.50,1.63) 100%, p<0.001
 Race/ethnicity Non-white vs white (reference) 9 1.27 (1.03,1.57) 99.6%, p<0.001
 Deprivation index Highest deprivation vs least (reference) 4 1.21 (1.18,1.24) 73.9%, p=0.009
 BMI category Highest BMI vs lowest BMI (reference) 8 1.55 (0.99,2.45) 99.6%, p<0.001
 Smoking status Current smoker vs never smoker (reference) 3 1.01 (0.90,1.14) 98.3%, p<0.001
Comorbidities
 No of comorbidities Most vs fewest (reference) 10 2.11 (1.60,2.79) 99.6%, p<0.001
 Cardiovascular disease Present vs absent (reference) 7 0.94 (0.81,1.10) 98.0%, p<0.001
 Diabetes Present vs absent (reference) 9 1.19 (0.93,1.52) 99.0%, p<0.001
 Dyslipidaemia Present vs absent (reference) 6 1.12 (0.92,1.37) 99.5%, p<0.001
 Hypertension Present vs absent (reference) 10 1.17 (0.98,1.40) 99.5%, p<0.001
 Mental illness Present vs absent (reference) 3 1.16 (0.79,1.70) 99.6%, p<0.001
 Depression Present vs absent (reference) 3 1.22 (0.85,1.74) 98.7%, p<0.001

BMI, body mass index.